Iqabane:

Uhlobo lwee-asethi:

Imvelaphi yeqabane:

Iinkcukacha zeNtsebenziswano:

Iqabane:

Uhlobo lwee-asethi:

Immuno-Oncology

Imvelaphi yeqabane:

IYuhan Corporation yenye yeenkampani ezinkulu zamayeza eKorea, eyasekwa kwiminyaka engama-80 eyadlulayo

Iinkcukacha zeNtsebenziswano:

I-Joint Venture ebizwa ngokuba yi-ImmuneOncia Therapeutics, LLC

Kugxilwe ekuphuhliseni nasekuthengiseni inani le-immune checkpoint antibodies ye-hematological malignancies kunye namathumba aqinileyo.

Iqabane:

Uhlobo lwee-asethi:

Immuno-Oncology

Imvelaphi yeqabane:

I-Lee's Pharm yinkampani yoluntu ye-biopharma eneminyaka engaphezu kwe-20 yokusebenza e-China kwaye ngoku ithengisa iimveliso ezili-14 kwi-PRC.

Iinkcukacha zeNtsebenziswano:

I-Sorrento inamalungelo akhethekileyo kwi-Lee's Pharm yokuphuhlisa kunye nokuthengisa i-anti-PD-L1 mAb STI-A1014 yabantu ngokupheleleyo kwimarike enkulu yaseTshayina.

Iqabane:

Uhlobo lwee-asethi:

Unyango lweSelula

Imvelaphi yeqabane:

I-Celularity sispin-off evela kwi-Celgene Corporation egxile kwi-placenta-derived kunye ne-cord-derived cells cell.

Iinkcukacha zeNtsebenziswano:

Utyalo-mali olulinganayo kunye noBumeli beBhodi

Iqabane:

Uhlobo lwee-asethi:

Immuno-oncology

Imvelaphi yeqabane:

I-MABPHARM yinkampani ye-biopharma egxile kwi-R & D kunye nokuveliswa kwamachiza amatsha kunye ne "Biobetters" yomhlaza kunye nezifo ezizimele.

Iinkcukacha zeNtsebenziswano:

I-Sorrento inelayisenisi ekhethekileyo yokuthengisa ii-Biobetters ezine ezigqibe izifundo zeSigaba se-3 e-China kuMntla Melika, iimarike zaseYurophu kunye ne-Japan.